nodes	percent_of_prediction	percent_of_DWPC	metapath
Alprazolam—CYP3A7—Cyclosporine—focal segmental glomerulosclerosis	0.234	0.282	CbGbCtD
Alprazolam—CYP3A7-CYP3A51P—Cyclosporine—focal segmental glomerulosclerosis	0.234	0.282	CbGbCtD
Alprazolam—CYP3A5—Cyclosporine—focal segmental glomerulosclerosis	0.175	0.212	CbGbCtD
Alprazolam—CYP2C9—Cyclosporine—focal segmental glomerulosclerosis	0.118	0.142	CbGbCtD
Alprazolam—CYP3A4—Cyclosporine—focal segmental glomerulosclerosis	0.0684	0.0825	CbGbCtD
Alprazolam—Altered state of consciousness—Cyclosporine—focal segmental glomerulosclerosis	0.00616	0.0359	CcSEcCtD
Alprazolam—Gastrointestinal symptom NOS—Cyclosporine—focal segmental glomerulosclerosis	0.00483	0.0282	CcSEcCtD
Alprazolam—Cerebration impaired—Cyclosporine—focal segmental glomerulosclerosis	0.00483	0.0282	CcSEcCtD
Alprazolam—Libido increased—Cyclosporine—focal segmental glomerulosclerosis	0.00467	0.0273	CcSEcCtD
Alprazolam—Menstrual disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00417	0.0243	CcSEcCtD
Alprazolam—Feeling hot—Cyclosporine—focal segmental glomerulosclerosis	0.00362	0.0211	CcSEcCtD
Alprazolam—Hyperaesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.00362	0.0211	CcSEcCtD
Alprazolam—Rigors—Cyclosporine—focal segmental glomerulosclerosis	0.00348	0.0203	CcSEcCtD
Alprazolam—Disturbance in attention—Cyclosporine—focal segmental glomerulosclerosis	0.00328	0.0192	CcSEcCtD
Alprazolam—Musculoskeletal stiffness—Cyclosporine—focal segmental glomerulosclerosis	0.00317	0.0185	CcSEcCtD
Alprazolam—Dysmenorrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.00313	0.0183	CcSEcCtD
Alprazolam—Urinary incontinence—Cyclosporine—focal segmental glomerulosclerosis	0.00275	0.016	CcSEcCtD
Alprazolam—Nightmare—Cyclosporine—focal segmental glomerulosclerosis	0.00275	0.016	CcSEcCtD
Alprazolam—Gynaecomastia—Cyclosporine—focal segmental glomerulosclerosis	0.00254	0.0148	CcSEcCtD
Alprazolam—Mental disability—Cyclosporine—focal segmental glomerulosclerosis	0.00247	0.0144	CcSEcCtD
Alprazolam—Hepatic function abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.00236	0.0138	CcSEcCtD
Alprazolam—Disorientation—Cyclosporine—focal segmental glomerulosclerosis	0.00231	0.0135	CcSEcCtD
Alprazolam—Hepatic failure—Cyclosporine—focal segmental glomerulosclerosis	0.0023	0.0134	CcSEcCtD
Alprazolam—Libido decreased—Cyclosporine—focal segmental glomerulosclerosis	0.00223	0.013	CcSEcCtD
Alprazolam—Hot flush—Cyclosporine—focal segmental glomerulosclerosis	0.00221	0.0129	CcSEcCtD
Alprazolam—Increased appetite—Cyclosporine—focal segmental glomerulosclerosis	0.0022	0.0128	CcSEcCtD
Alprazolam—Menopausal symptoms—Cyclosporine—focal segmental glomerulosclerosis	0.00219	0.0128	CcSEcCtD
Alprazolam—Lethargy—Cyclosporine—focal segmental glomerulosclerosis	0.00211	0.0123	CcSEcCtD
Alprazolam—Osteoarthritis—Cyclosporine—focal segmental glomerulosclerosis	0.00206	0.012	CcSEcCtD
Alprazolam—Disturbance in sexual arousal—Cyclosporine—focal segmental glomerulosclerosis	0.00205	0.012	CcSEcCtD
Alprazolam—Affect lability—Cyclosporine—focal segmental glomerulosclerosis	0.00203	0.0119	CcSEcCtD
Alprazolam—Mood swings—Cyclosporine—focal segmental glomerulosclerosis	0.00195	0.0114	CcSEcCtD
Alprazolam—Breast disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00186	0.0109	CcSEcCtD
Alprazolam—Cramp muscle—Cyclosporine—focal segmental glomerulosclerosis	0.00186	0.0108	CcSEcCtD
Alprazolam—Muscular weakness—Cyclosporine—focal segmental glomerulosclerosis	0.00182	0.0106	CcSEcCtD
Alprazolam—Dysphagia—Cyclosporine—focal segmental glomerulosclerosis	0.00178	0.0104	CcSEcCtD
Alprazolam—Sweating increased—Cyclosporine—focal segmental glomerulosclerosis	0.00174	0.0101	CcSEcCtD
Alprazolam—Abdominal discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.00171	0.00998	CcSEcCtD
Alprazolam—Dysuria—Cyclosporine—focal segmental glomerulosclerosis	0.00167	0.00974	CcSEcCtD
Alprazolam—Upper respiratory tract infection—Cyclosporine—focal segmental glomerulosclerosis	0.00166	0.00968	CcSEcCtD
Alprazolam—Pollakiuria—Cyclosporine—focal segmental glomerulosclerosis	0.00165	0.00962	CcSEcCtD
Alprazolam—Weight increased—Cyclosporine—focal segmental glomerulosclerosis	0.00162	0.00948	CcSEcCtD
Alprazolam—Weight decreased—Cyclosporine—focal segmental glomerulosclerosis	0.00161	0.00942	CcSEcCtD
Alprazolam—Infestation NOS—Cyclosporine—focal segmental glomerulosclerosis	0.00159	0.00928	CcSEcCtD
Alprazolam—Infestation—Cyclosporine—focal segmental glomerulosclerosis	0.00159	0.00928	CcSEcCtD
Alprazolam—Depression—Cyclosporine—focal segmental glomerulosclerosis	0.00159	0.00926	CcSEcCtD
Alprazolam—Jaundice—Cyclosporine—focal segmental glomerulosclerosis	0.00155	0.00905	CcSEcCtD
Alprazolam—Hepatobiliary disease—Cyclosporine—focal segmental glomerulosclerosis	0.0015	0.00878	CcSEcCtD
Alprazolam—Epistaxis—Cyclosporine—focal segmental glomerulosclerosis	0.0015	0.00876	CcSEcCtD
Alprazolam—Hepatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00143	0.00833	CcSEcCtD
Alprazolam—Hypoaesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.00142	0.00829	CcSEcCtD
Alprazolam—Urinary tract disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00141	0.00823	CcSEcCtD
Alprazolam—Connective tissue disorder—Cyclosporine—focal segmental glomerulosclerosis	0.0014	0.00819	CcSEcCtD
Alprazolam—Urethral disorder—Cyclosporine—focal segmental glomerulosclerosis	0.0014	0.00817	CcSEcCtD
Alprazolam—Tinnitus—Cyclosporine—focal segmental glomerulosclerosis	0.00133	0.00777	CcSEcCtD
Alprazolam—Angiopathy—Cyclosporine—focal segmental glomerulosclerosis	0.0013	0.00756	CcSEcCtD
Alprazolam—Mediastinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00129	0.00751	CcSEcCtD
Alprazolam—Chills—Cyclosporine—focal segmental glomerulosclerosis	0.00128	0.00748	CcSEcCtD
Alprazolam—Mental disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00125	0.0073	CcSEcCtD
Alprazolam—Malnutrition—Cyclosporine—focal segmental glomerulosclerosis	0.00124	0.00726	CcSEcCtD
Alprazolam—Tension—Cyclosporine—focal segmental glomerulosclerosis	0.00122	0.00712	CcSEcCtD
Alprazolam—Nervousness—Cyclosporine—focal segmental glomerulosclerosis	0.00121	0.00705	CcSEcCtD
Alprazolam—Muscle spasms—Cyclosporine—focal segmental glomerulosclerosis	0.00119	0.00698	CcSEcCtD
Alprazolam—Vision blurred—Cyclosporine—focal segmental glomerulosclerosis	0.00117	0.00684	CcSEcCtD
Alprazolam—Tremor—Cyclosporine—focal segmental glomerulosclerosis	0.00116	0.0068	CcSEcCtD
Alprazolam—Ill-defined disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00115	0.00673	CcSEcCtD
Alprazolam—Agitation—Cyclosporine—focal segmental glomerulosclerosis	0.00114	0.00667	CcSEcCtD
Alprazolam—Angioedema—Cyclosporine—focal segmental glomerulosclerosis	0.00114	0.00663	CcSEcCtD
Alprazolam—Malaise—Cyclosporine—focal segmental glomerulosclerosis	0.00112	0.00654	CcSEcCtD
Alprazolam—Vertigo—Cyclosporine—focal segmental glomerulosclerosis	0.00112	0.00652	CcSEcCtD
Alprazolam—Convulsion—Cyclosporine—focal segmental glomerulosclerosis	0.00108	0.00629	CcSEcCtD
Alprazolam—Arthralgia—Cyclosporine—focal segmental glomerulosclerosis	0.00106	0.00618	CcSEcCtD
Alprazolam—Chest pain—Cyclosporine—focal segmental glomerulosclerosis	0.00106	0.00618	CcSEcCtD
Alprazolam—Myalgia—Cyclosporine—focal segmental glomerulosclerosis	0.00106	0.00618	CcSEcCtD
Alprazolam—Anxiety—Cyclosporine—focal segmental glomerulosclerosis	0.00105	0.00616	CcSEcCtD
Alprazolam—Unspecified disorder of skin and subcutaneous tissue—Cyclosporine—focal segmental glomerulosclerosis	0.00105	0.00613	CcSEcCtD
Alprazolam—Discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.00105	0.0061	CcSEcCtD
Alprazolam—Dry mouth—Cyclosporine—focal segmental glomerulosclerosis	0.00103	0.00604	CcSEcCtD
Alprazolam—Confusional state—Cyclosporine—focal segmental glomerulosclerosis	0.00102	0.00597	CcSEcCtD
Alprazolam—Oedema—Cyclosporine—focal segmental glomerulosclerosis	0.00101	0.00592	CcSEcCtD
Alprazolam—Infection—Cyclosporine—focal segmental glomerulosclerosis	0.00101	0.00588	CcSEcCtD
Alprazolam—Nervous system disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000995	0.00581	CcSEcCtD
Alprazolam—Skin disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000985	0.00575	CcSEcCtD
Alprazolam—Hyperhidrosis—Cyclosporine—focal segmental glomerulosclerosis	0.00098	0.00572	CcSEcCtD
Alprazolam—Anorexia—Cyclosporine—focal segmental glomerulosclerosis	0.000967	0.00564	CcSEcCtD
Alprazolam—Musculoskeletal discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.000924	0.00539	CcSEcCtD
Alprazolam—Insomnia—Cyclosporine—focal segmental glomerulosclerosis	0.000917	0.00536	CcSEcCtD
Alprazolam—Paraesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.000911	0.00532	CcSEcCtD
Alprazolam—Dyspnoea—Cyclosporine—focal segmental glomerulosclerosis	0.000904	0.00528	CcSEcCtD
Alprazolam—Somnolence—Cyclosporine—focal segmental glomerulosclerosis	0.000902	0.00526	CcSEcCtD
Alprazolam—Dyspepsia—Cyclosporine—focal segmental glomerulosclerosis	0.000893	0.00521	CcSEcCtD
Alprazolam—Decreased appetite—Cyclosporine—focal segmental glomerulosclerosis	0.000882	0.00515	CcSEcCtD
Alprazolam—Gastrointestinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000876	0.00511	CcSEcCtD
Alprazolam—Fatigue—Cyclosporine—focal segmental glomerulosclerosis	0.000874	0.00511	CcSEcCtD
Alprazolam—Constipation—Cyclosporine—focal segmental glomerulosclerosis	0.000867	0.00506	CcSEcCtD
Alprazolam—Feeling abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.000836	0.00488	CcSEcCtD
Alprazolam—Gastrointestinal pain—Cyclosporine—focal segmental glomerulosclerosis	0.000829	0.00484	CcSEcCtD
Alprazolam—Urticaria—Cyclosporine—focal segmental glomerulosclerosis	0.000806	0.0047	CcSEcCtD
Alprazolam—Abdominal pain—Cyclosporine—focal segmental glomerulosclerosis	0.000802	0.00468	CcSEcCtD
Alprazolam—Body temperature increased—Cyclosporine—focal segmental glomerulosclerosis	0.000802	0.00468	CcSEcCtD
Alprazolam—Hypersensitivity—Cyclosporine—focal segmental glomerulosclerosis	0.000747	0.00436	CcSEcCtD
Alprazolam—Asthenia—Cyclosporine—focal segmental glomerulosclerosis	0.000728	0.00425	CcSEcCtD
Alprazolam—Pruritus—Cyclosporine—focal segmental glomerulosclerosis	0.000718	0.00419	CcSEcCtD
Alprazolam—Diarrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.000694	0.00405	CcSEcCtD
Alprazolam—Dizziness—Cyclosporine—focal segmental glomerulosclerosis	0.000671	0.00392	CcSEcCtD
Alprazolam—Vomiting—Cyclosporine—focal segmental glomerulosclerosis	0.000645	0.00376	CcSEcCtD
Alprazolam—Rash—Cyclosporine—focal segmental glomerulosclerosis	0.000639	0.00373	CcSEcCtD
Alprazolam—Dermatitis—Cyclosporine—focal segmental glomerulosclerosis	0.000639	0.00373	CcSEcCtD
Alprazolam—Headache—Cyclosporine—focal segmental glomerulosclerosis	0.000635	0.00371	CcSEcCtD
Alprazolam—Nausea—Cyclosporine—focal segmental glomerulosclerosis	0.000602	0.00352	CcSEcCtD
